Your browser doesn't support javascript.
loading
Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient-derived xenograft tumors.
Dhar, Deepanshi; Raina, Komal; Kumar, Dileep; Wempe, Michael F; Bagby, Stacey M; Pitts, Todd M; Orlicky, David J; Agarwal, Chapla; Messersmith, Wells A; Agarwal, Rajesh.
Afiliação
  • Dhar D; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
  • Raina K; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
  • Kumar D; Department of Pharmaceutical Sciences, South Dakota State University, Brookings, South Dakota.
  • Wempe MF; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
  • Bagby SM; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
  • Pitts TM; Division of Medical Oncology, School of Medicine, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
  • Orlicky DJ; Division of Medical Oncology, School of Medicine, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
  • Agarwal C; Department of Pathology, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
  • Messersmith WA; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
  • Agarwal R; Division of Medical Oncology, School of Medicine, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
Mol Carcinog ; 59(10): 1227-1240, 2020 10.
Article em En | MEDLINE | ID: mdl-32816368

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Extratos Vegetais / Resistencia a Medicamentos Antineoplásicos / Carcinoma Ductal Pancreático / Momordica charantia / Desoxicitidina / Modelos Animais de Doenças Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Carcinog Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Extratos Vegetais / Resistencia a Medicamentos Antineoplásicos / Carcinoma Ductal Pancreático / Momordica charantia / Desoxicitidina / Modelos Animais de Doenças Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Carcinog Ano de publicação: 2020 Tipo de documento: Article